Overview

• Certain human gut bacterial species absorb PFAS into intracellular clumps, shielding the microbes from toxin exposure.
• In mouse experiments, the introduced bacteria sequestered 25%–74% of ingested PFAS and expelled them in feces regardless of dose.
• The findings, published July 1 in Nature Microbiology, mark the first demonstration of microbial PFAS bioaccumulation in a living mammalian model.
• Lead authors Kiran Patil and Anna Lindell co-founded Cambiotics to develop probiotic formulations that boost PFAS-absorbing microbes in the gut.
• Cambiotics plans to initiate human testing to verify PFAS removal and aims to bring its first probiotic supplement to market by 2026.